Samenvatting
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess whether people with high-risk neuroblastoma have an additional benefit in terms of survival and tumor response of anti-GD2 antibody added to the post-consolidation therapy after high-dose chemotherapy and autologous hematopoietic stem cell transplantation as compared to placebo or no therapy, and whether anti-GD2 antibody has adverse events and impact on quality of life.
Originele taal-2 | Engels |
---|---|
Artikelnummer | CD012442 |
Tijdschrift | Cochrane Database of Systematic Reviews |
Volume | 2016 |
Nummer van het tijdschrift | 11 |
DOI's | |
Status | Gepubliceerd - 22 nov. 2016 |
Extern gepubliceerd | Ja |